Antonio Aguilera
Overview
Explore the profile of Antonio Aguilera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Illescas-Lopez M, Chaves-Blanco L, De Salazar A, Hernandez-Febles M, Carracedo R, Lagarejos E, et al.
Front Cell Infect Microbiol
. 2024 Jul;
14:1422299.
PMID: 38988808
Objectives: Precise HDV-RNA detection and quantification are pivotal for diagnosis and monitoring of response to newly approved treatment. We evaluate the performance of three HDV RNA detection and quantification assays....
2.
Gallego-Garcia P, Estevez-Gomez N, De Chiara L, Alvarino P, Juiz-Gonzalez P, Torres-Beceiro I, et al.
J Med Virol
. 2024 Jun;
96(7):e29773.
PMID: 38940448
The dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission are influenced by a variety of factors, including social restrictions and the emergence of distinct variants. In this study,...
3.
Caballero-Gomez J, Pereira S, Rivero-Calle I, Perez A, Viciana I, Casares-Jimenez M, et al.
J Pediatr
. 2024 May;
273:114125.
PMID: 38815747
Two of 11 children with acute hepatitis of unknown origin were found to have rat hepatitis E virus infection. This infection should be considered in the differential diagnosis of children...
4.
Gallego-Garcia P, Estevez-Gomez N, De Chiara L, Alvarino P, Juiz-Gonzalez P, Torres-Beceiro I, et al.
medRxiv
. 2024 Mar;
PMID: 38463998
The dynamics of SARS-CoV-2 transmission are influenced by a variety of factors, including social restrictions and the emergence of distinct variants. In this study, we delve into the origins and...
5.
Encinas B, Benito R, Rojo S, Reina G, Montiel N, Aguilera A, et al.
IJID Reg
. 2024 Feb;
10:146-149.
PMID: 38304758
Objectives: Human T-lymphotropic virus (HTLV) antenatal screening is not mandatory in Spain. Surveys conducted decades ago reported HTLV-1 seroprevalence rates of 0.2% among foreign pregnant women in Spain. The migrant...
6.
Chhabra A, Duarte Silva F, Mogharrabi B, Guirguis M, Ashikyan O, Rasper M, et al.
Eur Radiol
. 2024 Jan;
34(8):5228-5238.
PMID: 38244046
Objective: To determine the inter-reader reliability and diagnostic performance of classification and severity scales of Neuropathy Score Reporting And Data System (NS-RADS) among readers of differing experience levels after limited...
7.
Giammarino F, De Salazar A, Malet I, Vinuela L, Fuentes A, Saladini F, et al.
J Infect Dis
. 2024 Jan;
229(6):1796-1802.
PMID: 38206187
Background: Limited data are available regarding the susceptibility of the reverse transcriptase V106 polymorphism to doravirine. Methods: Doravirine susceptibility was measured in site-directed mutants (SDMs) containing V106I, V106A, V106M, and...
8.
Ayerdi O, Benito R, Ortega D, Aguilera A, Montiel N, Pintos I, et al.
Front Immunol
. 2023 Dec;
14:1277793.
PMID: 38143748
Background: HTLV-1 infection is a neglected disease, despite estimates of 10 million people infected worldwide and producing life-threatening illnesses in 10% of carriers. Sexual transmission is the main route of...
9.
Vinuela L, De Salazar A, Fuentes A, Serrano-Conde E, Falces-Romero I, Pinto A, et al.
J Med Virol
. 2023 Dec;
95(12):e29287.
PMID: 38084763
To evaluate the prevalence of transmitted drug resistance (TDR) to nucleoside and nonnucleoside reverse transcriptase inhibitors (NRTI, NNRTI), protease inhibitors (PI), and integrase strand transfer inhibitors (INSTI) in Spain during...
10.
de-Mendoza C, Perez L, Rando A, Reina G, Aguilera A, Benito R, et al.
J Clin Virol
. 2023 Nov;
169:105619.
PMID: 38000189
Background: HTLV-1 infection is a neglected disease. Over 10 million people are infected worldwide, with hot spots of high endemicity across all continents. Roughly 5% of HTLV-1 carriers develop HTLV-1-associated...